新型决策支持工具改善围手术期预防性抗生素处方
该研究在多院区三级医院网络中开发并实施了一种嵌入电子健康记录的计算机决策支持工具,根据手术名称、β-内酰胺过敏状态、MRSA状态和体重提供患者特异性手术抗菌预防建议。干预后适当抗生素给药率从77%升至92.5%,手术特异性抗生素选择和基于体重的剂量均有显著改善,NSQIP审计显示手术部位感染显著下降。
要点
- 决策支持工具基于手术名称、过敏状态、MRSA状态和体重提供个体化预防建议。
- 干预后适当抗生素给药率从77%升至92.5%,手术特异性选择和体重剂量显著改善。
- NSQIP审计显示干预实施后手术部位感染显著下降。
核心结论
- 基于患者特异性变量的决策支持工具显著改善了手术抗菌预防的适当选择并减少了手术部位感染。
研究设计与样本
- 在多院区三级医院网络开展的干预研究,干预为嵌入电子健康记录的计算机决策支持工具。
- 随机抽样审计了干预前后共408例手术 encounters,并利用NSQIP审计了21 912例手术。
主要发现
- 干预后适当抗生素给药率从77%(161/208)升至92.5%(185/200)(χ2=18.0,P<0.001)。
- 手术特异性抗生素选择从80.5%升至94.5%(χ2=19.3,P<0.001)。
- 基于体重的剂量从92.5%升至98.4%(χ2=7.45,P=0.006)。
- NSQIP审计的21 912例手术显示2022年6月实施干预后手术部位感染显著下降。
临床怎么用
- 可将患者手术名称、β-内酰胺过敏状态、MRSA状态和体重四变量嵌入电子健康记录以生成个体化预防建议。
- 术前使用经验证的两项问卷评估自我报告β-内酰胺过敏患者使用头孢唑林预防的安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Selection and dosing of surgical antimicrobial prophylaxis (SAP) to prevent surgical site infections (SSIs) is variable and often inappropriate in clinical settings resulting in increased risk of SSI. We therefore developed and implemented a novel computer decision-support tool to improve appropriate SAP selection specific to each patient's procedure and clinical context. METHODS: The intervention, performed at a multi-site tertiary hospital network, was a computer decision-support tool programmed within the hospital's electronic health record (EHR) to provide patient-specific SAP recommendations based on four variables: procedure name, patient's beta-lactam allergy status, MRSA status and weight. Safety of cefazolin prophylaxis among patients with self-reported beta-lactam allergy was established in the pre-operative clinic using a validated simple two-item questionnaire. Before each operation, a best practice SAP recommendation alert was provided to the anaesthesiologist based on the inputs from the four aforementioned variables. RESULTS: In the post-intervention period of 2 years, a total of ∼110 recommendation alerts were logged. A random sample audit of 408 surgical encounters were selected from the pre- and post-intervention periods. Overall, appropriate antibiotic administration rose from 77% (161/208) to 92.5% (185/200) (χ2 = 18.0, P < 0.001) post-intervention. Significant improvements were made for procedure-specific antibiotic selection (80.5% versus 94.5%; χ2 = 19.3, P < 0.001) and weight-based dosing (92.5% versus 98.4%; χ2 = 7.45, P = 0.006). Using National Surgical Quality Improvement Program (NSQIP) auditing of 21 912 surgeries showed a significant decline in SSIs following the implementation of the intervention in June 2022. CONCLUSION: In this first-ever intervention designed to direct SAP prescribing based on patient-specific variables, we significantly improved appropriate SAP selection and reduced SSIs across a comprehensive list of surgical procedures.
引用
- Mcintyre M, Esmail T, Kirkham K, et al. Improving perioperative prophylactic antibiotic prescribing using a novel decision-support tool. J Antimicrob Chemother. 2026. PMID: 41642611. doi:10.1093/jac/dkag015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。